Author:
Chen Hua-fei,Wang Wen-xian,Xu Chun-wei,Huang Li-chao,Li Xiao-feng,Lan Gang,Zhai Zhan-qiang,Zhu You-cai,Du Kai-qi,Lei Lei,Fang Mei-yu
Funder
Medical Scientific Research Foundation of Zhejiang Province of China
Zhejiang Public Welfare Technology Research Program
Science and Technology Planning Project of Zhejiang Province
Zhejiang Traditional Chinese Medicine Science Fund Project
Science and Technology Bureau Project of Jiaxing
Scientific Research Foundation of Zhejiang Medical Association
Xisike-Hanson Cancer Research Foundation
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference25 articles.
1. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin. Proc.,2008
2. Lung cancer: current therapies and new targeted treatments;Hirsch;Lancet,2017
3. ALK fusion partners impact response to ALK inhibition: differential effects on sensitivity, cellular phenotypes, and biochemical properties;Childress;Mol. Cancer Res.,2018
4. RECIST 1.1 - Standardisation and disease-specific adaptations: perspectives from the RECIST Working Group;Schwartz;Eur. J. Cancer,2016
5. Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer;Mohieldin;Cancer Manag. Res.,2018
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献